Advertisement

Topics

NEC and Transgene announce a collaboration in the field of individualized cancer immunotherapy, leveraging NEC's AI and Transgene's myvac platform

03:04 EDT 30 Oct 2018 | FinanzNachrichten

Regulatory News: NEC Corporation (NEC; TSE: 6701) and Transgene (Paris:TNG) (Euronext Paris: TNG) today announced the signing of a Memorandum of Understanding (MOU) for a strategic collaboration a...

Original Article: NEC and Transgene announce a collaboration in the field of individualized cancer immunotherapy, leveraging NEC's AI and Transgene's myvac platform

NEXT ARTICLE

More From BioPortfolio on "NEC and Transgene announce a collaboration in the field of individualized cancer immunotherapy, leveraging NEC's AI and Transgene's myvac platform"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...